Host tracheal and intestinal microbiomes inhibit Coccidioides growth in vitro .

Coccidioidomycosis is caused by a fungal pathogen that invades host lungs, causing respiratory distress. In 2019, 20,003 cases of Valley fever were reported to the CDC. However, this number likely vastly underrepresents the true number of Valley fever cases as many go undetected due to poor testing strategies and lack of diagnostic models. Valley fever is also often misdiagnosed as bacterial pneumonia, resulting in 60-80% of patients being treated with antibiotics prior to accurate diagnosis. Misdiagnosis contributes to a growing problem of antibiotic resistance and antibiotic induced microbiome dysbiosis, and the implications on disease outcome are currently unknown. 5%-10% of symptomatic Valley fever patients develop disseminated and/or chronic disease. Valley fever causes a significant financial burden and reduced quality of life. Little is known regarding what factors contribute to the development of chronic infection and treatments for disease are limited.